ClinicalTrials.Veeva

Menu

Fetal Anomalies Scan at the Time of Nuchal Translucency Study

S

Sheba Medical Center

Status

Unknown

Conditions

Fetal Anomalies

Study type

Observational

Funder types

Other

Identifiers

NCT00943189
SHEBA-08-4934-LG-CTIL

Details and patient eligibility

About

Purpose: Fetal anomalies scan at the time of Nuchal Translucency (NT) study.

Full description

Prospective study of patients at 12-14 weeks gestation that are coming for NT examination is conducted. Meticulous ultrasound examination will be done to the fetuses using trans vaginal and transabdominal techniques. The patients will receive only the NT information. Only in cases of detection of severe fetal anomalies the patient will get the information of the examination and counseling according to the findings. All patients will be asked to provide information of the 15 weeks early comprehensive ultrasound examination. The NT examination will be compared to the 15 weeks ultrasound. All patients will be asked to give information after delivery of the baby's health condition.

Enrollment

600 estimated patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • pregnant women at 12-14 weeks

Exclusion criteria

Trial contacts and locations

1

Loading...

Central trial contact

Liat Gindes, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems